The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials
Background: Obesity is a major risk factor for musculoskeletal disorders. Glucagon-like peptide-1 receptor (GLP-1R)–based agonists facilitate weight loss and may influence musculoskeletal health. However, whether GLP-1R based agonists are associated with the musculoskeletal adverse events during the...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publishing
2026-02-01
|
| Reeks: | Therapeutic Advances in Musculoskeletal Disease |
| Online toegang: | https://doi.org/10.1177/1759720X261428147 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|